Breaking News: NurExone Biologic Secures $2M in Private Placement and Completes First Tranche for $1.61M
The Future of Medicine: NurExone Biologic Inc. Announces Private Placement Offering TORONTO and HAIFA, Israel, Sept. 26, 2024 NurExone Biologic Inc. is making waves in the biopharmaceutical industry with their cutting-edge exosome-based therapies. With the announcement of a non-brokered private placement offering, the company is positioning itself for further growth and innovation. The Offering, totaling…